## **Core Concept**
Type I phenylketonuria (PKU) is a genetic disorder characterized by the inability to break down the amino acid phenylalanine (Phe). This condition results from a deficiency in an enzyme crucial for phenylalanine metabolism. The disorder leads to the accumulation of phenylalanine in the body, which can cause intellectual disability and other serious health problems if not treated.

## **Why the Correct Answer is Right**
The correct answer, **Phenylalanine hydroxylase**, is the enzyme deficient in Type I phenylketonuria. Phenylalanine hydroxylase (PAH) is responsible for converting phenylalanine into tyrosine, another amino acid. This conversion is critical because it not only reduces the levels of phenylalanine but also provides a precursor for the synthesis of neurotransmitters and other important molecules. A deficiency in PAH leads to the accumulation of phenylalanine.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not specify the correct enzyme related to phenylketonuria.
- **Option B:** This option is incorrect as it does not accurately represent the enzyme deficient in Type I PKU.
- **Option D:** This option is incorrect because it refers to another condition or enzyme, not related to the primary cause of Type I phenylketonuria.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that early diagnosis and dietary restriction of phenylalanine can significantly improve outcomes for individuals with Type I PKU. Newborn screening programs often include testing for PKU to allow for early intervention. A classic clinical correlation is that untreated PKU can lead to intellectual disability, seizures, and behavioral problems, emphasizing the importance of early and strict dietary management.

## **Correct Answer:** . Phenylalanine hydroxylase